Mustian Karen M, Morrow Gary R, Carroll Jennifer K, Figueroa-Moseley Colmar D, Jean-Pierre Pascal, Williams Geoffrey C
Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, James P Wilmot Cancer Center, Rochester, NY 14642, USA.
Oncologist. 2007;12 Suppl 1:52-67. doi: 10.1634/theoncologist.12-S1-52.
Cancer-related fatigue (CRF) is a debilitating, multi-faceted biopsychosocial symptom experienced by the majority of cancer survivors during and after treatment. CRF begins after diagnosis and frequently persists long after treatments end, even when the cancer is in remission. The etiological pathopsychophysiology underlying CRF is multifactorial and not well delineated. Mechanisms may include abnormal accumulation of muscle metabolites, dysregulation of the homeostatic status of cytokines, irregularities in neuromuscular function, abnormal gene expression, inadequate ATP synthesis, serotonin dysregulation, abnormal vagal afferent nerve activation, as well as an array of psychosocial mechanisms, including self-efficacy, causal attributions, expectancy, coping, and social support. An important first step in the management of CRF is the identification and treatment of associated comorbidities, such as anemia, hypothyroidism, pain, emotional distress, insomnia, malnutrition, and other comorbid conditions. However, even effective clinical management of these conditions will not necessarily alleviate CRF for a significant proportion of cancer survivors. For these individuals, intervention with additional therapeutic modalities may be required. The National Comprehensive Cancer Network guidelines recommend that integrative nonpharmacologic behavioral interventions be implemented for the effective management of CRF. These types of interventions may include exercise, psychosocial support, stress management, energy conservation, nutritional therapy, sleep therapy, and restorative therapy. A growing body of scientific evidence supports the use of exercise and psychosocial interventions for the management of CRF. Research on these interventions has yielded positive outcomes in cancer survivors with different diagnoses undergoing a variety of cancer treatments. The data from trials investigating the efficacy of other types of integrative nonpharmacologic behavioral therapies for the management of CRF, though limited, are also encouraging. This article provides an overview of current research on the relative merits of integrative nonpharmacologic behavioral interventions for the effective clinical management of CRF and makes recommendations for future research. Disclosure of potential conflicts of interest is found at the end of this article.
癌症相关疲劳(CRF)是大多数癌症幸存者在治疗期间及治疗后经历的一种使人衰弱的、多方面的生物心理社会症状。CRF在诊断后开始,并且即使在治疗结束后癌症处于缓解状态时,也常常会持续很长时间。CRF潜在的病因病理心理生理学是多因素的,且尚未完全明确。其机制可能包括肌肉代谢产物的异常积累、细胞因子稳态的失调、神经肌肉功能异常、基因表达异常、三磷酸腺苷(ATP)合成不足、血清素失调、迷走神经传入神经异常激活,以及一系列心理社会机制,包括自我效能感、因果归因、期望、应对方式和社会支持。CRF管理的重要第一步是识别和治疗相关的合并症,如贫血、甲状腺功能减退、疼痛、情绪困扰、失眠、营养不良和其他合并症。然而,即使对这些情况进行有效的临床管理,也不一定能使相当一部分癌症幸存者的CRF得到缓解。对于这些个体,可能需要采用其他治疗方式进行干预。美国国立综合癌症网络(National Comprehensive Cancer Network)指南建议实施综合非药物行为干预,以有效管理CRF。这类干预可能包括运动、心理社会支持、压力管理、能量节约、营养治疗、睡眠治疗和恢复性治疗。越来越多的科学证据支持使用运动和心理社会干预来管理CRF。对这些干预措施的研究已在接受各种癌症治疗的不同诊断的癌症幸存者中取得了积极成果。尽管研究其他类型的综合非药物行为疗法对CRF管理效果的试验数据有限,但也令人鼓舞。本文概述了目前关于综合非药物行为干预对CRF有效临床管理的相对优点的研究,并对未来研究提出了建议。本文末尾列出了潜在利益冲突的披露情况。